Revance Completes Enrollment in ASPEN-1 Phase 3 Pivotal Trial for Cervical Dystonia

Revance plans to announce topline results from the ASPEN-1 Phase 3 trial in the second half of 2020, and is currently enrolling patients in a Phase 2 trial for adult upper limb spasticity and a Phase 2 trial for plantar fasciitis.